JP2019510731A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510731A5 JP2019510731A5 JP2018528557A JP2018528557A JP2019510731A5 JP 2019510731 A5 JP2019510731 A5 JP 2019510731A5 JP 2018528557 A JP2018528557 A JP 2018528557A JP 2018528557 A JP2018528557 A JP 2018528557A JP 2019510731 A5 JP2019510731 A5 JP 2019510731A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- molecular weight
- polyalkylene glycol
- segment
- daltons
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 16
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 claims 5
- 229920001515 polyalkylene glycol Polymers 0.000 claims 4
- 208000036142 Viral infection Diseases 0.000 claims 3
- 229920001577 copolymer Polymers 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 3
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 239000007894 caplet Substances 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 208000037797 influenza A Diseases 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 238000004064 recycling Methods 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000037317 transdermal delivery Effects 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016900595 | 2016-02-19 | ||
| AU2016900595A AU2016900595A0 (en) | 2016-02-19 | Method for treatment of cancer or viral infection | |
| AU2016902715 | 2016-07-11 | ||
| AU2016902715A AU2016902715A0 (en) | 2016-07-11 | Method for treatment of cancer or viral infection | |
| PCT/AU2017/050139 WO2017139849A1 (en) | 2016-02-19 | 2017-02-17 | Anti-virus agent and method for treatment of viral infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019510731A JP2019510731A (ja) | 2019-04-18 |
| JP2019510731A5 true JP2019510731A5 (https=) | 2020-02-06 |
| JP6812436B2 JP6812436B2 (ja) | 2021-01-13 |
Family
ID=59624666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018528557A Active JP6812436B2 (ja) | 2016-02-19 | 2017-02-17 | 抗ウイルス薬およびウイルス感染症の治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11045491B2 (https=) |
| EP (1) | EP3416656B1 (https=) |
| JP (1) | JP6812436B2 (https=) |
| CN (1) | CN108472311B (https=) |
| AU (2) | AU2017220391B2 (https=) |
| ES (1) | ES2867453T3 (https=) |
| WO (1) | WO2017139849A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115397880B (zh) * | 2020-01-31 | 2025-06-17 | 瑞克制药有限公司 | 用于制备生物活性共聚物的工艺 |
| US20210330700A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
| WO2025129262A1 (en) * | 2023-12-21 | 2025-06-26 | Gramele Industrial Holdings Pty Ltd | Methods of ameliorating microbial growth |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3278126D1 (en) * | 1981-09-30 | 1988-03-31 | Nat Res Dev | Sustained release compositions |
| CN87108390A (zh) * | 1986-12-23 | 1988-09-21 | 生物聚合物有限公司 | 抑制生物和杀生物的组合物 |
| NZ222979A (en) | 1986-12-23 | 1990-09-26 | Biopolymers Ltd | Polymeric biocidal or biostatic compounds and compositions |
| AUPN327695A0 (en) | 1995-05-30 | 1995-06-22 | Chemeq Pty. Limited | Chemotherapeutic compositions |
| US6060571A (en) | 1996-02-22 | 2000-05-09 | Degussa Aktiengesellschaft | Acrolein-releasing copolymers |
| EP0792895B1 (de) * | 1996-02-22 | 2001-05-16 | Degussa AG | Acrolein freisetzende Copolymere |
| US6060235A (en) | 1997-09-19 | 2000-05-09 | Geltex Pharmaceuticals, Inc. | Antiviral polymers comprising acid functional groups and hydrophobic groups |
| US7629002B2 (en) | 2000-02-16 | 2009-12-08 | Chemeq Ltd. | Antimicrobial polymeric compositions and method of treatment using them |
| AU754178B2 (en) | 2000-02-16 | 2002-11-07 | Chemeq Ltd | Antimicrobial polymeric compositions |
| CN1617733B (zh) * | 2002-01-18 | 2010-04-07 | 凯米克有限公司 | 胃肠疾病的治疗方法和用于其中的聚合物组合物 |
| AUPS327102A0 (en) * | 2002-06-28 | 2002-07-18 | Chemeq Ltd | Method of treatment or prophylaxis of gastrointestinal diseases |
| BRPI0416298A (pt) * | 2003-11-06 | 2007-01-23 | Chemeq Ltd | método para manufatura de poliacroleìna |
| ES2556732T3 (es) * | 2007-11-07 | 2016-01-19 | Recce Limited | Polímeros anti-microbianos y sus composiciones |
| EP2186521A1 (en) * | 2008-11-14 | 2010-05-19 | Mergemeier Steffen | Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound |
| AU2010100972A4 (en) * | 2009-10-19 | 2010-10-07 | Chemeq Ltd | Topical antimicrobial compositions |
| WO2011047420A1 (en) * | 2009-10-19 | 2011-04-28 | Chemeq Ltd | Cosmetic compositions |
| US20190202908A1 (en) * | 2014-04-15 | 2019-07-04 | President And Fellows Of Harvard College | Bi-specific agents |
| JP6605602B2 (ja) * | 2014-11-18 | 2019-11-13 | レッセ ファーマシューティカルズ リミテッド | 細菌感染の治療のためのコポリマーおよび方法 |
-
2017
- 2017-02-17 WO PCT/AU2017/050139 patent/WO2017139849A1/en not_active Ceased
- 2017-02-17 AU AU2017220391A patent/AU2017220391B2/en active Active
- 2017-02-17 JP JP2018528557A patent/JP6812436B2/ja active Active
- 2017-02-17 EP EP17752574.8A patent/EP3416656B1/en active Active
- 2017-02-17 ES ES17752574T patent/ES2867453T3/es active Active
- 2017-02-17 US US15/771,858 patent/US11045491B2/en active Active
- 2017-02-17 CN CN201780005078.4A patent/CN108472311B/zh active Active
-
2021
- 2021-05-21 US US17/326,995 patent/US20210275573A1/en active Pending
-
2023
- 2023-03-28 AU AU2023201883A patent/AU2023201883B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hadidi et al. | Emerging plant proteins as nanocarriers of bioactive compounds | |
| JP2014240439A5 (https=) | ||
| Zhou et al. | Emerging inhalation aerosol devices and strategies: where are we headed? | |
| RU2019114665A (ru) | Противовирусные композиции для лечения инфекций, связанных с коронавирусами | |
| HRP20200925T1 (hr) | Pripravak za liječenje dijabetesa koji uključuje analog oksintomodulina | |
| JP2019510731A5 (https=) | ||
| SI2709613T1 (en) | Procedures for the treatment of HCV | |
| EP4628100A3 (en) | Anti-viral compounds and methods for administration thereof | |
| JP2013253101A5 (https=) | ||
| JP2012012418A5 (https=) | ||
| IL217243A (en) | Theophane 2-carboxylic acid derivatives, including pharmaceutical preparations and their uses for the preparation of flaviviridiae virus infections and hepatitis c virus infections | |
| JP2010537989A5 (https=) | ||
| JP2016518442A5 (https=) | ||
| JP2015529685A5 (https=) | ||
| FI3229828T3 (fi) | Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio | |
| JP2010285436A5 (https=) | ||
| EA201100809A1 (ru) | НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ, ВЫСОКООЧИЩЕННЫЙ, СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА АЛЬФА С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ | |
| NZ720863A (en) | Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment | |
| WO2016044839A3 (en) | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds | |
| JP2016535094A5 (https=) | ||
| JP2014533681A5 (https=) | ||
| RU2016117398A (ru) | Композиции полиинозиновой-полицитидиловой кислоты (поли (и:ц)) для лечения инфекций верхних дыхательных путей | |
| JP2010524882A5 (https=) | ||
| CN102488697B (zh) | 一种寡聚甘露糖醛酸在制备抗甲型h1n1流感病毒药物中的应用 | |
| RU2017142710A (ru) | Состав полиинозиновой-полицитидиловой кислоты (поли-(i:с)) на основе горохового крахмала для профилактики и/или лечения инфекций верхних дыхательных путей |